It's been 4 full months since the FDA granted approval to test in the US, and WOlgen says it will be another couple months before trials begin there. Ridiculous. They picked a fine time to move their office in the US. YOu would think they would have thought all that through before. Very unacceptable.
At the end of last year, he said it would be in the first quarter of this year.
Just nonstop delays with these guys.
On the next surge in share price, I'll unload a little. I've wasted too many years waiting on their broken promises.
I'll keep a core holding, but some money is better spent on other trades.
- Forums
- ASX - By Stock
- CUV
- wolgen interview
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.84%
!
$10.16

wolgen interview, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.16 |
Change
-0.190(1.84%) |
Mkt cap ! $509.2M |
Open | High | Low | Value | Volume |
$10.35 | $10.44 | $10.15 | $621.4K | 60.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2039 | $10.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.17 | 124 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1094 | 10.150 |
1 | 2000 | 10.140 |
2 | 410 | 10.100 |
1 | 1000 | 10.090 |
1 | 1000 | 10.080 |
Price($) | Vol. | No. |
---|---|---|
10.170 | 124 | 1 |
10.200 | 1995 | 1 |
10.290 | 30 | 1 |
10.500 | 100 | 1 |
10.570 | 1000 | 1 |
Last trade - 16.13pm 04/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online